Vol. 66 No. 4 (2017) | Medicina e Morale

Current Issue

Vol. 66 No. 4 (2017)

11 October 2017

View this Issue

Vol. 66 No. 4 (2017)

Published: 11 October 2017

Requires Subscription or Fee PDF (Italian) (EUR 25)

Editorial

Medicina personalizzata e medicina centrata sulla persona

Antonio G. Spagnolo

433-437

https://doi.org/10.4081/mem.2017.499

1129

PDF (Italian): 141
- PDF (Italian)

Original Articles

La tentazione dell'eutanasia neonatale nella gestione del neonato gravemente compromesso / The temptation of neonatal euthanasia in the management of seriously compromised infants

Roberta Spola

439-455

https://doi.org/10.4081/mem.2017.500

1291

PDF (Italian): 22
- Requires Subscription or Fee PDF (Italian) (EUR 15)
(Est)etica delle infezioni correlate all'assistenza / (Est)ethics of infections related to assistance

Massimiliano Colucci

457-473

https://doi.org/10.4081/mem.2017.501

1004

PDF (Italian): 11
- Requires Subscription or Fee PDF (Italian) (EUR 15)
Un'etica per la salute a partire dal concetto di malattia in senso cognitivista / An ethic for health from the concept of disease in a cognitivist perspective

Antonio Scoppettuolo

475-494

https://doi.org/10.4081/mem.2017.502

1037

PDF (Italian): 12
- Requires Subscription or Fee PDF (Italian) (EUR 15)
Il programma di eliminazione della filariasi linfatica in Bangladesh: un modello esportabile? / The lymphatic filariasis elimination programme in Bangladesh: an exportable model?

Elena Mancini

495-511

https://doi.org/10.4081/mem.2017.503

974

PDF (Italian): 6
- Requires Subscription or Fee PDF (Italian) (EUR 15)
Il dibattito legale ed etico sul divieto di commercio della maternità surrogata in India / The legal and moral debate leading to the ban of commercial surrogacy in India

Joseph Nixon, Olinda Timms

513-531

https://doi.org/10.4081/mem.2017.504

1134

PDF (Italian): 11
- Requires Subscription or Fee PDF (Italian) (EUR 15)
Il dibattito in Bioetica - I nuovi farmaci per l'HCV: una possibile "lezione metodologica" / The debate in Bioethics. The new drugs for HCV: a possible "methodological lesson"

Dario Sacchini

533-537

https://doi.org/10.4081/mem.2017.505

910

PDF (Italian): 20
- Requires Subscription or Fee PDF (Italian) (EUR 15)

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy